跳至主要内容
临床试验/EUCTR2009-012053-37-GB
EUCTR2009-012053-37-GB进行中(未招募)1 期

Dose response of FENO to inhaled steroids in mild-to-moderate asthma - Dose response of FENO to inhaled steroids in mild-to-moderate asthma

niversity of Dundee0 个研究点目标入组 25 人开始时间: 2009年9月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Informed consent and ability to perform exhaled nitric oxide assessment and all domiciliary measurements. Asthmatics taking 200-1000µg BDP per day or equivalent with FENO>30ppb which rises by at least a further 10ppb following withdrawal of ICS.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Recent respiratory infection (4 weeks) or oral steroid use within 3 months. Pregnancy or lactation, COPD, smoking within one year or >10pack years, known or suspected contra-indication to any of the IMP’s, potent CYP3A4 inhibitors/inducers

研究者

发起方
niversity of Dundee

相似试验